Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Mischoulon, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by David Mischoulon and Albert Yeung.
Connection Strength

3.486
  1. A pilot study of acupuncture monotherapy in patients with major depressive disorder. J Affect Disord. 2012 Dec 10; 141(2-3):469-73.
    View in: PubMed
    Score: 0.514
  2. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder. J Affect Disord. 2011 Apr; 130(1-2):285-9.
    View in: PubMed
    Score: 0.457
  3. Effectiveness of Mindful Self-Compassion Training Supported by Online Peer Groups in China: A Pilot Study. Altern Ther Health Med. 2021 Sep 24.
    View in: PubMed
    Score: 0.247
  4. Depressed Chinese Americans present predominantly psychological symptoms: A new trend or different outcomes due to methodological differences? Asian J Psychiatr. 2021 Jul; 61:102684.
    View in: PubMed
    Score: 0.241
  5. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder. J Affect Disord. 2020 02 01; 262:118-125.
    View in: PubMed
    Score: 0.217
  6. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. J Affect Disord. 2018 02; 227:198.
    View in: PubMed
    Score: 0.189
  7. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. J Affect Disord. 2017 Jan 15; 208:6-14.
    View in: PubMed
    Score: 0.175
  8. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study. J Psychiatr Res. 2015 Nov; 70:98-105.
    View in: PubMed
    Score: 0.162
  9. What is the role of alternative treatments in late-life depression? Psychiatr Clin North Am. 2013 Dec; 36(4):577-96.
    View in: PubMed
    Score: 0.142
  10. Acupuncture for depression: a review of clinical applications. Can J Psychiatry. 2012 Jul; 57(7):397-405.
    View in: PubMed
    Score: 0.130
  11. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. CNS Spectr. 2012 Jun; 17(2):76-86.
    View in: PubMed
    Score: 0.130
  12. Acupuncture for major depressive disorder: has its efficacy been disproved? J Clin Psychiatry. 2007 Oct; 68(10):1617; author reply 1617-8.
    View in: PubMed
    Score: 0.094
  13. Outcomes of recognizing depressed Chinese American patients in primary care. Int J Psychiatry Med. 2005; 35(3):213-24.
    View in: PubMed
    Score: 0.077
  14. Integrating psychiatry and primary care improves acceptability to mental health services among Chinese Americans. Gen Hosp Psychiatry. 2004 Jul-Aug; 26(4):256-60.
    View in: PubMed
    Score: 0.075
  15. Prevalence of major depressive disorder among Chinese-Americans in primary care. Gen Hosp Psychiatry. 2004 Jan-Feb; 26(1):24-30.
    View in: PubMed
    Score: 0.072
  16. Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors. Front Psychiatry. 2020; 11:584711.
    View in: PubMed
    Score: 0.059
  17. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. Am J Psychiatry. 2020 10 01; 177(10):965-973.
    View in: PubMed
    Score: 0.057
  18. Major depressive disorder and insomnia: Exploring a hypothesis of a common neurological basis using waking and sleep-derived heart rate variability. J Psychiatr Res. 2020 04; 123:89-94.
    View in: PubMed
    Score: 0.055
  19. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause. Psychoneuroendocrinology. 2020 02; 112:104512.
    View in: PubMed
    Score: 0.054
  20. Longer-term open-label study of adjunctive riluzole in treatment-resistant depression. J Affect Disord. 2019 11 01; 258:102-108.
    View in: PubMed
    Score: 0.053
  21. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomed Laser Surg. 2018 Dec; 36(12):634-646.
    View in: PubMed
    Score: 0.050
  22. A case control series for the effect of photobiomodulation in patients with low back pain and concurrent depression. Laser Ther. 2018 Sep 30; 27(3):167-173.
    View in: PubMed
    Score: 0.050
  23. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction. Lasers Surg Med. 2019 02; 51(2):127-135.
    View in: PubMed
    Score: 0.050
  24. Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry J. 2015; 2015:352979.
    View in: PubMed
    Score: 0.040
  25. College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity. Ann Clin Psychiatry. 2015 May; 27(2):100-8.
    View in: PubMed
    Score: 0.040
  26. Celebrity suicides and their differential influence on suicides in the general population: a national population-based study in Korea. Psychiatry Investig. 2015 Apr; 12(2):204-11.
    View in: PubMed
    Score: 0.039
  27. Predictors of stable personality disorder diagnoses in outpatients with remitted depression. J Nerv Ment Dis. 2002 Apr; 190(4):248-56.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.